In current prospective randomized double-blinded clinical trial, 60 patients, candidate for femoral fracture surgery with conture, with grade I or II of American society of anesthesiology (ASA), will be evaluated. Patients with hypersensitivity to tranexamic acid, coagulopathies and pregnancy will be excluded. All patients will undergo routine heparin administration, a day before surgery and required laboratory tests including coagulation factors and complete blood count will be collected. Anesthesia will be inducted using propofol, fentanyl, midazolam and atracurium. Patients randomly will be assigned to study groups via RAS software. In study group, 10 mg/kg tranexamic acid will be administered during 15 minutes prior to incision, and will be infused during surgery with dosage of 1 mg/kg/hr till end of the surgery. In control group, patients will receive normal saline serum as placebo in same volume of tranexamic acid during surgery. Maximum allowable blood loss formula will be used to evaluate intraoperative bleeding. Whereas, Intraoperative blood loss will be estimated by blinded anesthesiologist, using blood collected in suction reservoir and blood smeared gausses.
During surgery and postoperatively, variables such as intraoperative bleeding, postoperative bleeding and blood transfusion during and after surgery will be assessed and recorded.